Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

17 alpha-hydroxyprogesterone caproate has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies

Compound Research Comparison

Studies
(17 alpha-hydroxyprogesterone caproate)
Trials
(17 alpha-hydroxyprogesterone caproate)
Recent Studies (post-2010)
(17 alpha-hydroxyprogesterone caproate)
Studies
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Trials
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
517882512,57727327

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deering, SH; Gotkin, JL; Hoeldtke, NJ; Howard, BC; Napolitano, PG; Paonessa, DJ; Shields, AD1
Foglia, LM; Hill, DL; Hoeldtke, NJ; Napolitano, PG; Paonessa, DJ; Zelig, CM1

Other Studies

2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619.
    American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Angiotensin II; Cytokines; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Vasoconstriction

2006
Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619.
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Arteries; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Regional Blood Flow; Vasoconstriction

2010